Hybrid Systems of Delivery of Long-Acting Drugs Based on Gentamicin Sulfate, Silver, and Copper Nanoparticles, and Gelatin Biopolymer Matrices
- 作者: Shabatina T.I.1, Vernaya O.I.1, Karlova D.L.1, Nuzhdina A.V.1, Shabatin V.P.1, Semenov A.M.1, Lozinskii V.I.2, Mel’nikov M.Y.1
-
隶属关系:
- Moscow State University
- Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
- 期: 卷 13, 编号 9-10 (2018)
- 页面: 546-550
- 栏目: Nanobiology
- URL: https://journals.rcsi.science/2635-1676/article/view/220656
- DOI: https://doi.org/10.1134/S1995078018050130
- ID: 220656
如何引用文章
详细
Using the method of cryochemical synthesis, systems of prolonged release of gentamicin sulfate modified with silver (2–30 nm) and copper (1–9 nm) nanoparticles from cryostructured biopolymer matrices based on gelatin with a pore size of 10‒50 μm are obtained. The composition and structure of the systems are confirmed by the data of IR, UV, and NMR spectroscopy; TEM; SEM; and thermoanalytical methods of analysis, and the rate of release of the drug is determined by conductometry. Hybrid composites based on metals and gentamicin sulfate showed greater activity in suppressing the growth of E. coli 52 and S. aureus 144 than their components separately.
作者简介
T. Shabatina
Moscow State University
编辑信件的主要联系方式.
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
O. Vernaya
Moscow State University
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
D. Karlova
Moscow State University
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
A. Nuzhdina
Moscow State University
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
V. Shabatin
Moscow State University
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
A. Semenov
Moscow State University
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
V. Lozinskii
Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119334
M. Mel’nikov
Moscow State University
Email: tatyanashabatina@yandex.ru
俄罗斯联邦, Moscow, 119991
补充文件
